Wang Xiaohui 4

4 · iQIYI, Inc. · Filed May 13, 2026

AI-generated summary of this filing

Updated May 13, 2026

iQIYI (IQ) Chief Content Officer Wang Xiaohui Receives Option Grants

What Happened

Wang Xiaohui, iQIYI's Chief Content Officer, was involved in derivative transactions on May 11, 2026 that show the cancellation/disposition of 1,531,250 and 7,500,000 prior awards and the simultaneous grant/acquisition of 1,531,250 and 7,500,000 new derivative awards (total 9,031,250). These are reported as derivative option-type awards (prices listed as N/A), not open-market stock sales or purchases. Per the filing footnotes, the reported actions include amendments that extend the options’ expiration date (as amended, options expire 10/18/2030).

Key Details

Transaction date: 2026-05-11; Form 4 filed 2026-05-13 (appears timely within the usual 2-business-day window).
Amounts: Dispositions of 1,531,250 and 7,500,000 prior derivative awards; corresponding grants/acquisitions of 1,531,250 and 7,500,000 new derivative awards (total 9,031,250).
Price/Value: N/A on the Form 4 — these are option/derivative transactions, not open-market trades with a cash price.
Vesting/terms (summary from footnotes): the 1,531,250 tranche is described as vesting over four years with 25% on the 1st anniversary of 05/11/2026 and the remaining 75% in 12 equal quarterly installments; the 7,500,000 tranche is described as vesting over four years with 25% vesting on each of the 1st–4th anniversaries of 05/11/2026. Footnotes also indicate some prior options were fully vested and that the amendments extended expiration dates to 10/18/2030.
Shares owned after transaction: not specified in the provided summary of the filing.
Filing timeliness: filed 2 days after the reported transactions; appears timely.

Context

These filings reflect option/award amendments and regrants (derivative transactions), not immediate sales or purchases of common stock; no cash proceeds or open-market activity is shown. Option grants/amendments affect potential future dilution and executive compensation timelines but do not by themselves represent a buy or sell signal. For full legal and quantitative details (exact vesting language, exercise price, prior option terms), consult the complete Form 4 and its footnotes.

Form 4

Period: 2026-05-11

Chief Content Officer

Transactions

Disposition to Issuer
Option (right to buy)
[F4][F3]
2026-05-11−1,531,250→ 0 total
Exercise: $0.51Exp: 2027-02-14→ Class A ordinary share (1,531,250 underlying)
Award
Option (right to buy)
[F4][F3]
2026-05-11+1,531,250→ 1,531,250 total
Exercise: $0.51Exp: 2030-10-18→ Class A ordinary share (1,531,250 underlying)
Disposition to Issuer
Option (right to buy)
[F6][F5]
2026-05-11−7,500,000→ 0 total
Exercise: $0.51Exp: 2028-02-28→ Class A ordinary share (7,500,000 underlying)
Award
Option (right to buy)
[F6][F5]
2026-05-11+7,500,000→ 7,500,000 total
Exercise: $0.51Exp: 2030-10-18→ Class A ordinary share (7,500,000 underlying)

Holdings

Option (right to buy)
[F1]
Exercise: $0.51Exp: 2036-05-11→ Class A ordinary share (2,275,000 underlying)
2,275,000
Option (right to buy)
[F2]
Exercise: $0.00Exp: 2036-05-11→ Class A ordinary share (2,450,000 underlying)
2,450,000

Footnotes (6)

[F1]The options vest over a four-year period, with 25% vesting on the 1st anniversary of 05/11/2026, and the remaining 75% vesting in 12 equal quarterly installments beginning one calendar quarter after the date of the aforesaid anniversary.
[F2]The options vest over a four-year period, with 25% vesting on each of the 1st, 2nd, 3rd and 4th anniversary of 05/11/2026.
[F3]The options have fully vested over a four-year period, with 25% vested on the 1st anniversary of 02/14/2017, and the remaining 75% vested in 12 equal quarterly installments beginning one calendar quarter after the date of the aforesaid anniversary.
[F4]The two reported transactions involved an amendment of outstanding options to extend the expiration date, which may be deemed a cancellation of the original options (to expire on 02/14/2027) and grant of new options. As amended, the options expire on 10/18/2030.
[F5]The options have fully vested over a four-year period, with 25% vested on the 1st anniversary of 02/28/2018, and the remaining 75% vested in 12 equal quarterly installments beginning one calendar quarter after the date of the aforesaid anniversary.
[F6]The two reported transactions involved an amendment of outstanding options to extend the expiration date, which may be deemed a cancellation of the original options (to expire on 02/28/2028) and grant of new options. As amended, the options expire on 10/18/2030.

Signature

/s/ Wang Xiaohui|2026-05-13

1 file